Drug Makers Openly Reward Indian Doctors For Prescriptions
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers openly offer rewards to physicians for prescribing their products, according to an examination of industry practices. Torrent Pharmaceutical of India held a contest for doctors and rewarded the top 100 prescribers at a public drawing and sponsored other doctors and their families to go to Istanbul during an international medical symposium. Torrent is not alone in rewarding high-prescribing doctors in India. Regulators in several other countries have banned the practice, but the Indian government relies on the drug industry to regulate itself and physicians to behave ethically. (Click here for more
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.